Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)
China · Delayed Price · Currency is CNY 13.09
-0.12 (-0.91%)
May 20, 2026, 12:54 PM CST
SHE:002737 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -204.65 | -257.83 | 492.05 | 1,119 | 867.22 | 704.74 |
Depreciation & Amortization | 170.23 | 170.23 | 181.04 | 181.2 | 268.81 | 167.77 |
Other Amortization | 7.36 | 7.36 | 3.61 | 2.05 | 1.77 | 2.17 |
Loss (Gain) From Sale of Assets | 0.65 | 0.65 | 0.24 | -3.23 | -7.43 | -47.77 |
Asset Writedown & Restructuring Costs | 46.79 | 46.79 | 25.79 | 0.48 | 26.43 | 29.68 |
Loss (Gain) From Sale of Investments | -34.94 | -34.94 | -11.95 | -30.58 | 9.92 | -26.36 |
Provision & Write-off of Bad Debts | -9.82 | -9.82 | 7.63 | -4.6 | 1.06 | 27.05 |
Other Operating Activities | -70.37 | 6.41 | 47.6 | 54.88 | 39.18 | 52.53 |
Change in Accounts Receivable | 421.49 | 421.49 | -415.02 | 77.04 | 26.33 | 38.45 |
Change in Inventory | 229.95 | 229.95 | -25.49 | -241.47 | 73.5 | -152.67 |
Change in Accounts Payable | 23.14 | 23.14 | -634.38 | -286.2 | 662.12 | 57.9 |
Change in Other Net Operating Assets | - | - | 2.77 | 25.66 | 15.16 | 10.43 |
Operating Cash Flow | 551.36 | 574.97 | -307.48 | 889.69 | 1,975 | 865.23 |
Operating Cash Flow Growth | - | - | - | -54.96% | 128.30% | -26.04% |
Capital Expenditures | -116.22 | -96.1 | -92.79 | -149.16 | -152.9 | -118.31 |
Sale of Property, Plant & Equipment | 0.56 | 0.52 | 0.33 | 4.05 | 3.98 | 0.69 |
Cash Acquisitions | - | - | - | - | - | -1.1 |
Divestitures | -0.06 | -0.06 | - | - | - | - |
Investment in Securities | 270.97 | -492.46 | 60.53 | 147.7 | -517.45 | -790.76 |
Other Investing Activities | 35.13 | 35.48 | 34.47 | 33.61 | 21.94 | 19.76 |
Investing Cash Flow | 190.38 | -552.62 | 2.54 | 36.2 | -644.43 | -889.72 |
Short-Term Debt Issued | - | 118 | 0.02 | 14.43 | - | - |
Long-Term Debt Issued | - | - | - | - | 420 | 306.58 |
Total Debt Issued | 118 | 118 | 0.02 | 14.43 | 420 | 306.58 |
Short-Term Debt Repaid | - | -13 | -10 | -420 | - | - |
Long-Term Debt Repaid | - | -4.12 | -6.7 | -6.47 | -238.12 | -383.49 |
Total Debt Repaid | -17.12 | -17.12 | -16.7 | -426.47 | -238.12 | -383.49 |
Net Debt Issued (Repaid) | 100.88 | 100.88 | -16.68 | -412.04 | 181.88 | -76.91 |
Issuance of Common Stock | - | - | - | - | 22.13 | 28.01 |
Common Dividends Paid | -292.73 | -292.12 | -885.2 | -588.51 | -416.7 | -212.19 |
Other Financing Activities | -19.1 | -18.95 | -40.63 | -38.28 | -33.87 | -48.24 |
Financing Cash Flow | -210.95 | -210.19 | -942.51 | -1,039 | -246.57 | -309.33 |
Foreign Exchange Rate Adjustments | -0.35 | -0.19 | -0.3 | 0.23 | -0.02 | - |
Net Cash Flow | 530.45 | -188.04 | -1,248 | -112.71 | 1,084 | -333.82 |
Free Cash Flow | 435.14 | 478.86 | -400.27 | 740.52 | 1,822 | 746.92 |
Free Cash Flow Growth | - | - | - | -59.37% | 144.00% | -21.96% |
Free Cash Flow Margin | 17.42% | 20.66% | -11.85% | 12.99% | 35.77% | 16.74% |
Free Cash Flow Per Share | 0.75 | - | -0.68 | 1.27 | 3.11 | 1.28 |
Cash Income Tax Paid | 234.46 | 232.58 | 459.29 | 723.41 | 579.81 | 565.31 |
Levered Free Cash Flow | 552.69 | 606.36 | -507.07 | 349.11 | 1,537 | 698.11 |
Unlevered Free Cash Flow | 555 | 608.67 | -504.85 | 352.84 | 1,543 | 704.48 |
Change in Working Capital | 646.11 | 646.11 | -1,053 | -429.66 | 768.39 | -44.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.